Phase III Assessment of Safety and Efficacy of Thymus Nuclear Protein Injections for treating CDC stage-2 HIV-1 infected patients.
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2009
At a glance
- Drugs VGV 1 (Primary)
- Indications HIV-1 infections
- Focus Registrational; Therapeutic Use
- 24 Nov 2005 New trial record.